<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v9i11.12871</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Benefit Analysis and Discussion of the Same Disease in Different Departments of Public Hospitals under the DIP Payment Method </title><url>https://artdesignp.com/journal/JCNR/9/11/10.26689/jcnr.v9i11.12871</url><author>SongShanlan,ZhuShengshan,WangHeng</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>11</issue><history><date date-type="pub"><published-time>2025-12-05</published-time></date></history><abstract>Objective: This study aims to explore the benefit analysis of the same disease in different departments of public hospitals under the DIP payment method. Methods: This study is a retrospective analysis that selected clinical data from patients who received treatment in the Department of Orthopedics and the Department of Acupuncture and Moxibustion at our hospital from January 1, 2023, to December 31, 2023. The study compared the costs of medications, examinations, treatments, laboratory tests, nursing and other expenses, and total treatment costs between the two departments. It analyzed the cost structure of the two departments and proposed further improvement suggestions. Results: The study results indicated that the total costs in the Department of Acupuncture and Moxibustion were significantly higher than those in the Department of Orthopedics. Among medication costs, the total medication costs in the Department of Orthopedics were higher than those in the Department of Acupuncture and Moxibustion, with costs for Western medicine, proprietary Chinese medicine, and herbal medicine all being higher (p &amp;lt; 0.05). Regarding examination costs, consultation fees in the Department of Orthopedics were lower than those in the Department of Acupuncture and Moxibustion, while examination costs were higher (p &amp;lt; 0.05). In terms of treatment costs, orthopedic treatment and surgical fees were higher than those in the Department of Acupuncture and Moxibustion (p &amp;lt; 0.05). For laboratory test costs, orthopedic laboratory fees were significantly higher than those in the Department of Acupuncture and Moxibustion (p &amp;lt; 0.05). Among nursing and other expenses, orthopedic blood transfusion, bed fees, and other expenses were higher than those in the Department of Acupuncture and Moxibustion, while nursing fees were lower (p &amp;lt; 0.05). Conclusion: Treatment fees in the Department of Acupuncture and Moxibustion are the core and account for a relatively high proportion of the total costs. The benefits generated by the Department of Orthopedics are primarily derived from medication, examination, and laboratory fees, aligning with the characteristics of combining diagnosis, medication, and surgical intervention in orthopedic treatment. Consultation fees, nursing fees, and bed fees in the Department of Acupuncture and Moxibustion are higher than those in the Department of Orthopedics, indicating a longer treatment cycle in acupuncture, which warrants clinical attention.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Tan S, Shu Y, Wu J, et al., 2025, Analysis of the Interactive Effects of Diagnosis-Related Groups-Based Payment and Pre-Hospitalization Model. Chinese Hospital Management, 45(7): 25–29.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Zhou M, Cui J, Wang J, et al., 2024, Quantitative Analysis of the Effectiveness of DRG/DIP Payment Reform. China Health Insurance, 2024(7): 68–75.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Chang C, Huang J, Hurst J, et al., 2024, Benefits of Dapagliflozin in Chronic Kidney Disease for US Commercial Payers: A Cost-Offset Analysis. Journal of Managed Care &amp; Specialty Pharmacy, 30(8): 834–842.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Pizzi L, Jutkowitz E, Prioli K, et al., 2021, Cost-Benefit Analysis of the COPE Program for Persons Living with Dementia: Toward a Payment Model. Innovation in Aging, 6(1): 1–11.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Li X, Chen X, Wang Y, et al., 2024, Analysis of the Implementation of DIP Payment System in the Nephrology Department of a Grade A Tertiary Hospital in Henan Province. Hospital Management Forum, 41(2): 15–18.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Xu D, Xiao P, Teng J, 2024, Analysis of Factors Contributing to Deviation Cases Under the Diagnosis-Related Groups-Based Payment Model. Modern Hospital Management, 22(3): 89–91.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Zhou M, Cui J, Wang J, et al., 2024, Quantitative Analysis of the Effectiveness of DRG/DIP Payment Reform: Taking Monitoring Points and Representative Cities as Examples. China Health Insurance, 2024(7): 68–75.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Wei D, Wang F, Li A, et al., 2023, Effectiveness of Using PDCA to Prevent and Control Multidrug-Resistant Organism Infections in Hospitalized Patients. Chinese Journal of Infection Control, 22(4): 478–483.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Lan Y, Peng F, Gan L, et al., 2025, Benefit Prediction and Management Research on Large Medical Equipment in Day Surgery Centers Under the Diagnosis-Related Groups-Based Payment Model. China Medical Equipment, 22(6): 146–150 + 157.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
